NCT02029222View on ClinicalTrials.gov

Photon Versus Particle Therapy for Recurrent Lung Cancer; a Planning Study Based on a Reference Dataset of Patients.

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
NSCLC
Trial Locations (1)

6229 ET

Maastricht Radiation Oncology, Maastricht

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

collaborator

University of Wisconsin, Madison

OTHER

lead

Maastricht Radiation Oncology

OTHER

NCT02029222 - Photon Versus Particle Therapy for Recurrent Lung Cancer; a Planning Study Based on a Reference Dataset of Patients. | Biotech Hunter | Biotech Hunter